ArticleJournal of geriatric cardiology : JGC2026
CT-derived fractional flow reserve combined with atherosclerotic extent to determine long-term outcomes in diabetic patients with coronary artery disease.
Article in Journal of geriatric cardiology : JGC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is still limited data on predictive value of coronary computed tomography angiography (CCTA)-derived fractional flow reserve (CT-FFR) for long term outcomes. We examined the long-term prognostic value of CT-FFR combined with CCTA-defined atherosclerotic extent in diabetic patients with coronary artery disease (CAD). Methods: A retrospective pooled analysis of individual patient data was performed. Deep-learning-based vessel-specific CT-FFR was calculated. All patients enrolled were followed-up for at least 5 years. Predictive abilities for major adverse cardiac events (MACE) were compared among three models (model 1, constructed using clinical variables; model 2, model 1+CCTA-derived atherosclerotic extent (Leiden risk score); and model 3, model 2+CT-FFR. Results: A total of 480 diabetic patients [median age, 61 (55-66) years; 52.9% men] were included. During a median follow-up time of 2197 (2126-2355) days, 55 patients (11.5%) experienced MACE. In multivariate-adjusted Cox models, Leiden risk score (HR: 1.06; 95% CI: 1.01-1.11; Conclusion: In diabetic patients with CAD, CT-FFR provides robust and incremental prognostic information for predicting long-term outcomes. The combined model exhibits improved prediction abilities, which is beneficial for risk stratification.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.